In the BioHarmony Drug Report Database

"Preview" Icon

Levodopa

Bendopa, Dopar, Inbrija, Larodopa (levodopa) is a small molecule pharmaceutical. Levodopa was first approved as Bendopa on 1982-01-01. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. It is known to target G-protein coupled receptor 143 and L-DOPA dioxygenase. Sinemet’s patents are valid until 2032-11-16 (FDA).

 

Trade Name

 

Inbrija
 

Common Name

 

levodopa
 

ChEMBL ID

 

CHEMBL1009
 

Indication

 

parkinson disease
 

Drug Class

 

Dopamine receptor agonists

Image (chem structure or protein)

Levodopa structure rendering